{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T17:14:57Z","timestamp":1790874897595,"version":"4.1.0"},"reference-count":44,"publisher":"MDPI AG","issue":"13","license":[{"start":{"date-parts":[[2022,6,22]],"date-time":"2022-06-22T00:00:00Z","timestamp":1655856000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institute of Health\/National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["U01HL112707"],"award-info":[{"award-number":["U01HL112707"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institute of Health\/National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["U01HL112695"],"award-info":[{"award-number":["U01HL112695"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Rationale: Subjective cognitive difficulties are common among sarcoidosis patients; however, previous studies have not modeled the link between cognitive difficulties and health-related quality of life (HRQOL). Objectives: To determine whether cognitive difficulties are associated with HRQOL in sarcoidosis patients after adjusting for demographics, fatigue, and physical disease severity measures. Methods: We performed a secondary analysis of the Genomic Research in Alpha-1 antitrypsin Deficiency and Sarcoidosis (GRADS) study data. We examined the association between self-reported cognitive difficulties (Cognitive Failures Questionnaire (CFQ)) and HRQOL (SF12v2 mental and physical component scores) while adjusting for the demographics, fatigue, and physical disease severity measures (i.e., organ involvement, forced vital capacity). Results: Approximately one-fourth of the patients with sarcoidosis endorsed cognitive difficulties. More frequent cognitive difficulties and more severe fatigue were significantly associated with worse mental HRQOL in the fully adjusted model, while older age was associated with better mental HRQOL. The association between cognitive difficulties and physical HRQOL was not significant in the final model. More severe fatigue, joint involvement, and reduced forced vital capacity (FVC) were associated with worse physical HRQOL, while higher income and higher education were associated with better physical HRQOL. Conclusions: Perceived cognitive difficulties are associated with diminished HRQOL after adjusting for demographics, organ involvement, pulmonary function, and fatigue. The association between cognitive difficulties and reduced HRQOL primarily occurs through the impact on mental components of HRQOL.<\/jats:p>","DOI":"10.3390\/jcm11133594","type":"journal-article","created":{"date-parts":[[2022,6,22]],"date-time":"2022-06-22T21:31:06Z","timestamp":1655933466000},"page":"3594","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Cognitive Difficulties and Health-Related Quality of Life in Sarcoidosis: An Analysis of the GRADS Cohort"],"prefix":"10.3390","volume":"11","author":[{"given":"Karin","family":"Hoth","sequence":"first","affiliation":[{"name":"Department of Psychiatry, University of Iowa, Iowa City, IA 52242, USA"},{"name":"Iowa Neuroscience Institute, University of Iowa, Iowa City, IA 52242, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob","family":"Simmering","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of Iowa, Iowa City, IA 52242, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Croghan","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, University of Iowa, Iowa City, IA 52242, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nabeel","family":"Hamzeh","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of Iowa, Iowa City, IA 52242, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,6,22]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.1164\/rccm.202002-0251ST","article-title":"Diagnosis and detection of sarcoidosis. An official american thoracic society clinical practice guideline","volume":"201","author":"Crouser","year":"2020","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1097\/MCP.0000000000000505","article-title":"Multisystemic manifestations of sarcoidosis and comorbidities","volume":"24","author":"Korsten","year":"2018","journal-title":"Curr. Opin. Pulm. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.ccm.2015.08.013","article-title":"Consequences of Sarcoidosis","volume":"36","author":"Drent","year":"2015","journal-title":"Clin. Chest Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.rmed.2012.02.007","article-title":"Unexpectedly high prevalence of sarcoidosis in a representative U.S. Metropolitan population","volume":"106","author":"Erdal","year":"2012","journal-title":"Respir. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1055\/s-2007-970337","article-title":"Quality of life and health status in sarcoidosis: A review","volume":"28","author":"Drent","year":"2007","journal-title":"Semin. Respir. Crit. Care Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.ccm.2008.03.003","article-title":"Quality of life and health status in sarcoidosis: A review of the literature","volume":"29","author":"Drent","year":"2008","journal-title":"Clin. Chest Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s11136-013-0438-1","article-title":"A conceptual model of health-related quality of life in sarcoidosis","volume":"23","author":"Victorson","year":"2014","journal-title":"Qual. Life Res."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1097\/MCP.0b013e3283050a4f","article-title":"Quality of life evaluation in sarcoidosis: Current status and future directions","volume":"14","author":"Victorson","year":"2008","journal-title":"Curr. Opin. Pulm. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.genhosppsych.2008.04.010","article-title":"Quality of life, anxiety and depression in sarcoidosis","volume":"30","author":"Goracci","year":"2008","journal-title":"Gen. Hosp. Psychiatry"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1097\/MCP.0000000000000079","article-title":"Health-related quality of life in sarcoidosis","volume":"20","author":"Korenromp","year":"2014","journal-title":"Curr. Opin. Pulm. Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.ccm.2015.08.014","article-title":"Quality of life assessment in sarcoidosis","volume":"36","author":"Judson","year":"2015","journal-title":"Clin. Chest Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1055\/s-0037-1602589","article-title":"Quality of life in sarcoidosis","volume":"38","author":"Judson","year":"2017","journal-title":"Semin. Respir. Crit. Care Med."},{"key":"ref_13","first-page":"96","article-title":"Effect of gender on health related quality of life in sarcoidosis","volume":"27","author":"Bourbonnais","year":"2010","journal-title":"Sarcoidosis Vasc. Diffus. Lung Dis."},{"key":"ref_14","first-page":"99","article-title":"Gender differences in sarcoidosis: Symptoms, quality of life, and medical consumption","volume":"30","author":"Drent","year":"1999","journal-title":"Women Health"},{"key":"ref_15","first-page":"837","article-title":"Health related quality of life regarding to gender in sarcoidosis","volume":"33","author":"Gvozdenovic","year":"2009","journal-title":"Coll. Antropol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1164\/rccm.201906-1250OC","article-title":"Income and other contributors to poor outcomes in U.S. patients with sarcoidosis","volume":"201","author":"Harper","year":"2020","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_17","first-page":"31","article-title":"Fatigue in sarcoidosis and exercise tolerance, dyspnea, and quality of life","volume":"833","author":"Ziora","year":"2015","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1378\/chest.130.4.989","article-title":"Fatigue is associated with quality of life in sarcoidosis patients","volume":"130","author":"Michielsen","year":"2006","journal-title":"Chest"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3109\/09286586.2010.483754","article-title":"Quality of life in sarcoidosis: Comparing the impact of ocular and non-ocular involvement of the disease","volume":"17","author":"Saligan","year":"2010","journal-title":"Ophthalmic Epidemiol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.rmed.2015.01.019","article-title":"The effect of corticosteroids on quality of life in a sarcoidosis clinic: The results of a propensity analysis","volume":"109","author":"Judson","year":"2015","journal-title":"Respir. Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"190057","DOI":"10.1183\/16000617.0057-2019","article-title":"The effects of pharmacological interventions on quality of life and fatigue in sarcoidosis: A systematic review","volume":"29","author":"Vis","year":"2020","journal-title":"Eur. Respir. Rev."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"S415","DOI":"10.1513\/AnnalsATS.201707-563OT","article-title":"Executive summary of the NHLBI workshop report: Leveraging current scientific advancements to understand sarcoidosis variability and improve outcomes","volume":"14","author":"Maier","year":"2017","journal-title":"Ann. Am. Thorac. Soc."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"S421","DOI":"10.1513\/AnnalsATS.201707-564OT","article-title":"Disease burden and variability in sarcoidosis","volume":"14","author":"Gerke","year":"2017","journal-title":"Ann. Am. Thorac. Soc."},{"key":"ref_24","first-page":"212","article-title":"Everyday cognitive failure in sarcoidosis: The prevalence and the effect of anti-TNF-alpha treatment","volume":"80","author":"Elfferich","year":"2010","journal-title":"Respir. Int. Rev. Thorac. Dis."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1016\/j.rmed.2017.11.008","article-title":"Everyday cognitive failure and depressive symptoms predict fatigue in sarcoidosis: A prospective follow-up study","volume":"138s","author":"Hendriks","year":"2018","journal-title":"Respir. Med."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.2044-8260.1982.tb01421.x","article-title":"The Cognitive Failures Questionnaire (CFQ) and its correlates","volume":"21","author":"Broadbent","year":"1982","journal-title":"Br. J. Clin. Psychol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1513\/AnnalsATS.201503-143OC","article-title":"Rationale and design of the genomic research in Alpha-1 Antitrypsin Deficiency and Sarcoidosis (GRADS) study. Sarcoidosis Protocol","volume":"12","author":"Strange","year":"2015","journal-title":"Ann. Am. Thorac. Soc."},{"key":"ref_28","unstructured":"(1999). Statement on sarcoidosis: Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. Am. J. Respir. Crit. Care Med., 160, 736\u2013755."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1164\/ajrccm.164.10.2104046","article-title":"Clinical characteristics of patients in a case control study of sarcoidosis","volume":"164","author":"Baughman","year":"2001","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_30","first-page":"19","article-title":"The WASOG sarcoidosis organ assessment instrument: An update of a previous clinical tool","volume":"31","author":"Judson","year":"2014","journal-title":"Sarcoidosis Vasc. Diffus. Lung Dis."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1183\/09031936.05.00034505","article-title":"General considerations for lung function testing","volume":"26","author":"Miller","year":"2005","journal-title":"Eur. Respir. J."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.jval.2016.05.019","article-title":"Update to the report of nationally representative values for the noninstitutionalized US adult population for five health-related quality-of-life scores","volume":"19","author":"Hanmer","year":"2016","journal-title":"Value Health"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1080\/00221300209602098","article-title":"The cognitive failures questionnaire revisited: Dimensions and correlates","volume":"129","author":"Wallace","year":"2002","journal-title":"J. Gen. Psychol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1177\/1073191108324440","article-title":"Factor structure and measurement invariance of the cognitive failures questionnaire across the adult life span","volume":"16","author":"Rast","year":"2009","journal-title":"Assessment"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1080\/00140139.2013.821172","article-title":"Psychometric properties of the cognitive failures questionnaire\u2020","volume":"56","author":"Bridger","year":"2013","journal-title":"Ergonomics"},{"key":"ref_36","first-page":"2","article-title":"Everyday cognitive failure in patients suffering from neurosarcoidosis","volume":"36","author":"Voortman","year":"2019","journal-title":"Sarcoidosis Vasc. Diffus. Lung Dis."},{"key":"ref_37","first-page":"117","article-title":"Association between physical functions and quality of life in sarcoidosis","volume":"31","author":"Drent","year":"2014","journal-title":"Sarcoidosis Vasc. Diffus. Lung Dis."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.chest.2015.11.025","article-title":"Age-related differences in health-related quality of life in COPD: An analysis of the COPDGene and SPIROMICS Cohorts","volume":"149","author":"Martinez","year":"2016","journal-title":"Chest"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.2147\/NDT.S199746","article-title":"Cognitive impairment in depression: Recent advances and novel treatments","volume":"15","author":"Perini","year":"2019","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jad.2007.06.006","article-title":"A review on cognitive impairments in depressive and anxiety disorders with a focus on young adults","volume":"106","author":"Castaneda","year":"2008","journal-title":"J. Affect. Disord."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1097\/AJP.0000000000000536","article-title":"The relationship between chronic pain and neurocognitive function: A systematic review","volume":"34","author":"Higgins","year":"2018","journal-title":"Clin. J. Pain"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1097\/YCO.0000000000000106","article-title":"Impact of sleep on the risk of cognitive decline and dementia","volume":"27","author":"Spira","year":"2014","journal-title":"Curr. Opin. Psychiatry"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1097\/MCP.0b013e32832d0403","article-title":"Fatigue in sarcoidosis: A systematic review","volume":"15","author":"Lower","year":"2009","journal-title":"Curr. Opin. Pulm. Med."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1097\/JGP.0b013e3181b208ef","article-title":"Subjective cognitive complaints relate to white matter hyperintensities and future cognitive decline in patients with cardiovascular disease","volume":"17","author":"Haley","year":"2009","journal-title":"Am. J. Geriatr. Psychiatry"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/11\/13\/3594\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T23:37:33Z","timestamp":1760139453000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/11\/13\/3594"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,22]]},"references-count":44,"journal-issue":{"issue":"13","published-online":{"date-parts":[[2022,7]]}},"alternative-id":["jcm11133594"],"URL":"https:\/\/doi.org\/10.3390\/jcm11133594","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,22]]}}}